"Smith and Yue have done an admirable job with this volume. There is a clear logic in the arrangement of the chapters. The introductory chapter is well suited to readers who are not familiar with this particular topic. Jargon is kept to a bar minimum . . . This highly readable volume should serve to get newcomers to the field up to speed quite quickly." – D. Eric Walters, Department of Biochemistry and Molecular Biology, Rosalind Franklin University of Medicine, in Journal of Medicinal Chemistry, 2007, Vol. 50, No. 19"Providing up-to-date, in-depth coverage in a single volume, Inhibitors of Cyclin-dependent Kinases as Anti-Tumor Agents surveys the success of the agents developed thus far, the possibility of new routes to more selective inhibitors, and the growing appreciation of critical, therapeutic issues." – In Anticancer Research, Sept/ Oct 2007, Vol. 27, No. 5A

• Section 1: Provides a conceptual framework. Section 2: Focuses on the aspects of CDK Inhibitors as functional anticancer agents. Section 3: Chemistry.

"Smith and Yue have done an admirable job with this volume. There is a clear logic in the arrangement of the chapters. The introductory chapter is well suited to readers who are not familiar with this particular topic. Jargon is kept to a bar minimum . . . This highly readable volume should serve to get newcomers to the field up to speed quite quickly." – D. Eric Walters, Department of Biochemistry and Molecular Biology, Rosalind Franklin University of Medicine, in Journal of Medicinal Chemistry, 2007, Vol. 50, No. 19"Providing up-to-date, in-depth coverage in a single volume, Inhibitors of Cyclin-dependent Kinases as Anti-Tumor Agents surveys the success of the agents developed thus far, the possibility of new routes to more selective inhibitors, and the growing appreciation of critical, therapeutic issues." – In Anticancer Research, Sept/ Oct 2007, Vol. 27, No. 5A

• Section 1: Provides a conceptual framework. Section 2: Focuses on the aspects of CDK Inhibitors as functional anticancer agents. Section 3: Chemistry.

"Smith and Yue have done an admirable job with this volume. There is a clear logic in the arrangement of the chapters. The introductory chapter is well suited to readers who are not familiar with this particular topic. Jargon is kept to a bar minimum . . . This highly readable volume should serve to get newcomers to the field up to speed quite quickly." – D. Eric Walters, Department of Biochemistry and Molecular Biology, Rosalind Franklin University of Medicine, in Journal of Medicinal Chemistry, 2007, Vol. 50, No. 19"Providing up-to-date, in-depth coverage in a single volume, Inhibitors of Cyclin-dependent Kinases as Anti-Tumor Agents surveys the success of the agents developed thus far, the possibility of new routes to more selective inhibitors, and the growing appreciation of critical, therapeutic issues." – In Anticancer Research, Sept/ Oct 2007, Vol. 27, No. 5A

• Section 1: Provides a conceptual framework. Section 2: Focuses on the aspects of CDK Inhibitors as functional anticancer agents. Section 3: Chemistry.